Galmed Pharmaceuticals Ltd. (EOCN)
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
Eocene Ltd.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.07M shares outstanding
No company description available.
Leadership
Allen Baharaff
Co-Founder, President, CEO & Chairman
Yohai Stenzler
Chief Accounting Officer
Guy Nehemya
COO & Data Protection Officer
Doron Cohen
Chief Financial Officer
Employees
--
Country
--
Sector
Healthcare
Website
--
| Name | Shares | % | Source |
|---|---|---|---|
CVI Investments, Inc. · may incl. warrants· filed Nov 2025 | 173.3K | 3.1% as filed | 13G |
 Baharaff Allen Chief Executive Officer, Director | 100.0K | 9.4% | FORM 4 |
CITADEL ADVISORS LLC | 86.9K | 8.1% | 13F |
Allen Baharaff · superseded by Form 4· filed Feb 2025 | 44.1K | 2.6% as filed | 13G |
HRT FINANCIAL LP | 42.1K | 3.9% | 13F |
 Cohen Doron Leib Chief Financial Officer | 25.0K | 2.3% | FORM 4 |
 Nehemya Guy Chief Operating Officer | 25.0K | 2.3% | FORM 4 |
 Stenzler Yohai Chief Accounting Officer | 25.0K | 2.3% | FORM 4 |
XTX Topco Ltd | 15.0K | 1.4% | 13F |
 Nir Shmuel Director | 12.5K | 1.2% | FORM 4 |
Insiders
- Baharaff AllenChief Executive Officer, Director
- Cohen Doron LeibChief Financial Officer
- Nehemya GuyChief Operating Officer
- Stenzler YohaiChief Accounting Officer
- Nir ShmuelDirector
- Poshinski AmirDirector
- SIDRANSKY DAVIDDirector
based on 1.07M shares outstanding
30d Avg
7.82K
60d Avg
14.85K
90d Avg
14.85K